We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

START - Early Thrombocyte Administration to Patients With Ruptured Abdominal Aortic Aneurism (rAAA)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01291290
Recruitment Status : Unknown
Verified March 2013 by Thomas Bech Jorgensen, Rigshospitalet, Denmark.
Recruitment status was:  Recruiting
First Posted : February 8, 2011
Last Update Posted : March 14, 2013
Information provided by (Responsible Party):

February 7, 2011
February 8, 2011
March 14, 2013
March 2010
March 2014   (Final data collection date for primary outcome measure)
Mortality [ Time Frame: 30 days ]
Mortality during the first 30days after randomization, and time to death during the 30 days.
Same as current
Complete list of historical versions of study NCT01291290 on ClinicalTrials.gov Archive Site
  • Acute myocardial infarction [ Time Frame: 30 days ]
    Development of AMI during the first 30 days after randomization, and the time to development during the first 30 days.
  • Post operative kidney failure [ Time Frame: 30 days ]
    The need for dialysis during the first 30 days, time to start of dialysis and length.
  • Post operative pulmonary insufficiency [ Time Frame: 30 days ]
    Length of respirator treatment in the ICU during the first 30 days.
  • Length of stay in ICU [ Time Frame: until discharged from ICU ]
    Length of stay in ICU
  • Length of stay in hospital [ Time Frame: until discharged from hospital ]
    Until discharged from main surgical department or if transferred to local hospital, when the patient leave local hospital.
Same as current
Not Provided
Not Provided
START - Early Thrombocyte Administration to Patients With Ruptured Abdominal Aortic Aneurism
Thrombocyte Administration Versus no Thrombocytes to Patients With Ruptured Abdominal Aortic Aneurism Before Transport to Hospital With Vascular Surgical Department
The purpose of this study is to investigate the effect of platelet infusion prior to transfer to a vascular surgical department in patients with a ruptured abdominal aortic aneurism.
Not Provided
Not Provided
Allocation: Randomized
Intervention Model: Single Group Assignment
Masking: Triple (Participant, Investigator, Outcomes Assessor)
Primary Purpose: Treatment
Ruptured Abdominal Aortic Aneurism
Procedure: Platelet
2 portions of platelets (one portion = pooled from 4 donors, 350ml) infused when diagnosed with rAAA and vascular surgeon accepts to receive the patient, infused before transportation.
Other Names:
  • Thrombocyte
  • Platelets
  • No Intervention: Control treatment
    Usual transfusion regime to patients with rAAA
  • Experimental: Thrombocyte
    Early thrombocyte administration to patients with rAAA
    Intervention: Procedure: Platelet
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
Unknown status
March 2015
March 2014   (Final data collection date for primary outcome measure)

Inclusion Criteria:

  • diagnosed with rAAA either by clinical evaluation or CT or UL

Exclusion Criteria:

  • formerly randomized in the study
  • aneurism not ruptured during operation
Sexes Eligible for Study: All
Child, Adult, Senior
Contact information is only displayed when the study is recruiting subjects
Not Provided
Not Provided
Thomas Bech Jorgensen, Rigshospitalet, Denmark
Rigshospitalet, Denmark
Not Provided
Study Chair: Henning Bay Nielsen, MD
Rigshospitalet, Denmark
March 2013

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP